Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%

In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to prevent tuberculosis (TB), as part of the agreement with Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, an official release said on Thursday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2WxX3d4
via IFTTT